Bridgeway Capital Management, LLC Lyra Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.55 - $6.53 $250,250 - $359,150	-55,000 Reduced 38.79%	86,800 $539,000
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $132,750 - $216,000	45,000 Added 46.49%	141,800 $554,000
Q2 2023 Aug 14, 2023	SELL	$1.98 - $4.33 $99,000 - $216,500	-50,000 Reduced 34.06%	96,800 $397,000
Q4 2022 Feb 14, 2023	BUY	$2.44 - $5.42 $219,356 - $487,258	89,900 Added 158.0%	146,800 $460,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $7.51 $41,200 - $75,100	-10,000 Reduced 14.95%	56,900 $321,000
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $8,440 - $18,820	-2,000 Reduced 2.9%	66,900 $292,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $163,620 - $254,610	27,000 Added 64.44%	68,900 $630,000
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $49,061 - $89,389	-7,100 Reduced 14.49%	41,900 $336,000
Q4 2020 Feb 16, 2021	BUY	$9.28 - $13.88 $454,719 - $680,120	49,000 New	49,000 $559,000

32.2M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.05M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.